Amphastar Pharma (AMPH) Tops Q3 EPS by 1c

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.12, $0.01 better than the analyst estimate of $0.11. Revenue for the quarter came in at $75.5 million versus the consensus estimate of $74.73 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
• Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan